LifeMD, Inc.

The momentum for this stock is not very good. LifeMD, Inc. has good growth characteristics. LifeMD, Inc. is not very popular among insiders. LifeMD, Inc. is a mediocre stock to choose.
Log in to see more information.

News

LifeMD's Series A Preferred Stock Yield Pushes Past 10%
LifeMD's Series A Preferred Stock Yield Pushes Past 10%

Preferred Stock Channel In trading on Thursday, shares of LifeMD Inc's 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) were yielding above the 10% mark based on its quarterly dividend (annualized to...\n more…

LifeMD: Selling WorkSimpli Could Be A Catalyst
LifeMD: Selling WorkSimpli Could Be A Catalyst

SeekingAlpha LifeMD: Selling WorkSimpli Could Be A Catalyst...\n more…

LifeMD to Participate in Three Investor Conferences During September
LifeMD to Participate in Three Investor Conferences During September

Globe Newswire NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following...\n more…

LifeMD (NASDAQ:LFMD) Receives New Coverage from Analysts at B. Riley
LifeMD (NASDAQ:LFMD) Receives New Coverage from Analysts at B. Riley

Ticker Report B. Riley assumed coverage on shares of LifeMD (NASDAQ:LFMD - Free Report) in a research report sent to investors on Friday morning, StockNewsAPI reports. The brokerage issued a buy rating and a...\n more…

LifeMD shares 'significantly undervalued' versus peers, says B. Riley
LifeMD shares 'significantly undervalued' versus peers, says B. Riley

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Analysts Set LifeMD, Inc. (NASDAQ:LFMD) Target Price at $12.17
Analysts Set LifeMD, Inc. (NASDAQ:LFMD) Target Price at $12.17

Ticker Report Shares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have earned an average rating of "Buy" from the six ratings firms that are covering the stock, Marketbeat.com reports. Six analysts have rated...\n more…